Cargando…
DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis
Diabetic retinopathy (DR) is a significant reason for the global increase in visual loss. Studies show that timely treatment can significantly bring down such incidents. Hence, it is essential to distinguish the stages and severity of DR to recommend needed medical attention. In this view, this pape...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051933/ https://www.ncbi.nlm.nih.gov/pubmed/33897905 http://dx.doi.org/10.1007/s11760-021-01904-7 |
_version_ | 1783679831574052864 |
---|---|
author | Kumar, Gaurav Chatterjee, Shraban Chattopadhyay, Chiranjoy |
author_facet | Kumar, Gaurav Chatterjee, Shraban Chattopadhyay, Chiranjoy |
author_sort | Kumar, Gaurav |
collection | PubMed |
description | Diabetic retinopathy (DR) is a significant reason for the global increase in visual loss. Studies show that timely treatment can significantly bring down such incidents. Hence, it is essential to distinguish the stages and severity of DR to recommend needed medical attention. In this view, this paper presents DRISTI (Diabetic Retinopathy classIfication by analySing reTinal Images), where a hybrid deep learning model composed of VGG16 and capsule network is proposed, which yields statistically significant performance improvement over the state of the art. To validate our claim, we have reported detailed experimental and ablation studies. We have also created an augmented dataset to increase the APTOS dataset’s size and check how robust the model is. The five-class training and validation accuracy for the expanded dataset is [Formula: see text] and [Formula: see text] . The two-class training and validation accuracy on augmented APTOS is [Formula: see text] and [Formula: see text] . Extending the two-class model for the mixed dataset, we get a training and validation accuracy of [Formula: see text] and [Formula: see text] , respectively. We have also performed cross-dataset and mixed dataset testing to demonstrate the efficiency of DRISTI. |
format | Online Article Text |
id | pubmed-8051933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-80519332021-04-19 DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis Kumar, Gaurav Chatterjee, Shraban Chattopadhyay, Chiranjoy Signal Image Video Process Original Paper Diabetic retinopathy (DR) is a significant reason for the global increase in visual loss. Studies show that timely treatment can significantly bring down such incidents. Hence, it is essential to distinguish the stages and severity of DR to recommend needed medical attention. In this view, this paper presents DRISTI (Diabetic Retinopathy classIfication by analySing reTinal Images), where a hybrid deep learning model composed of VGG16 and capsule network is proposed, which yields statistically significant performance improvement over the state of the art. To validate our claim, we have reported detailed experimental and ablation studies. We have also created an augmented dataset to increase the APTOS dataset’s size and check how robust the model is. The five-class training and validation accuracy for the expanded dataset is [Formula: see text] and [Formula: see text] . The two-class training and validation accuracy on augmented APTOS is [Formula: see text] and [Formula: see text] . Extending the two-class model for the mixed dataset, we get a training and validation accuracy of [Formula: see text] and [Formula: see text] , respectively. We have also performed cross-dataset and mixed dataset testing to demonstrate the efficiency of DRISTI. Springer London 2021-04-16 2021 /pmc/articles/PMC8051933/ /pubmed/33897905 http://dx.doi.org/10.1007/s11760-021-01904-7 Text en © The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Kumar, Gaurav Chatterjee, Shraban Chattopadhyay, Chiranjoy DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title | DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title_full | DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title_fullStr | DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title_full_unstemmed | DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title_short | DRISTI: a hybrid deep neural network for diabetic retinopathy diagnosis |
title_sort | dristi: a hybrid deep neural network for diabetic retinopathy diagnosis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051933/ https://www.ncbi.nlm.nih.gov/pubmed/33897905 http://dx.doi.org/10.1007/s11760-021-01904-7 |
work_keys_str_mv | AT kumargaurav dristiahybriddeepneuralnetworkfordiabeticretinopathydiagnosis AT chatterjeeshraban dristiahybriddeepneuralnetworkfordiabeticretinopathydiagnosis AT chattopadhyaychiranjoy dristiahybriddeepneuralnetworkfordiabeticretinopathydiagnosis |